Cargando…
Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
INTRODUCTION: Diabetes mellitus (DM) stands out as one of the chronic diseases with the highest morbidity and mortality rates worldwide. Among the many complications of DM, diabetic retinopathy (DR) is one of the causes of blindness in patients aged between 20 and 64 years. At least 90% of the new c...
Autores principales: | Ribeiro de Carvalho, Giuliana, Loduca Lima, Vagner, da Veiga, Glaucia Luciano, Adami, Fernando, da Costa Aguiar Alves, Beatriz, Cristiano Pereira, Edimar, Feder, David, Fonseca, Fernando Luiz Affonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495346/ https://www.ncbi.nlm.nih.gov/pubmed/32982347 http://dx.doi.org/10.2147/DMSO.S243873 |
Ejemplares similares
-
Expression of DNA repair genes in association with ionizing radiation
por: Machi Jr, Amaury, et al.
Publicado: (2022) -
Survivin expression as a prognostic marker for breast cancer
por: Quidute, Patricia, et al.
Publicado: (2023) -
Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008) -
Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013) -
Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
por: El-Batarny, Ashraf M
Publicado: (2007)